247 related articles for article (PubMed ID: 36641471)
21. Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma.
Yang X; Li S; Xu C; Liu S; Zhang X; Lian B; Li M
Cancer Biol Ther; 2024 Dec; 25(1):2365449. PubMed ID: 38865161
[TBL] [Abstract][Full Text] [Related]
22. USP10 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells.
Hou S; Zhao T; Deng B; Li C; Li W; Huang H; Hang Q
Med Oncol; 2023 Dec; 41(1):33. PubMed ID: 38150085
[TBL] [Abstract][Full Text] [Related]
23. Homeobox A7 promotes esophageal squamous cell carcinoma progression through C-C motif chemokine ligand 2-mediated tumor-associated macrophage recruitment.
Feng A; He L; Jiang J; Chu Y; Zhang Z; Fang K; Wang Z; Li Z; Sun M; Zhao Z; Shi J; Zhang L; Chen T; Xu M
Cancer Sci; 2023 Aug; 114(8):3270-3286. PubMed ID: 37248653
[TBL] [Abstract][Full Text] [Related]
24. PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis.
Zhao M; Lu T; Bi G; Hu Z; Liang J; Bian Y; Feng M; Zhan C
Biomed Pharmacother; 2023 Dec; 168():115711. PubMed ID: 37879213
[TBL] [Abstract][Full Text] [Related]
25. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.
Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M
Front Immunol; 2023; 14():1162032. PubMed ID: 37187751
[TBL] [Abstract][Full Text] [Related]
26. HSF1 expression in tumor-associated macrophages promotes tumor cell proliferation and indicates poor prognosis in esophageal squamous cell carcinoma.
Li Y; Li Q; Liu J; Huang Y; Mao J; Zhang G
Clin Transl Oncol; 2023 Jun; 25(6):1682-1689. PubMed ID: 36586067
[TBL] [Abstract][Full Text] [Related]
27. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
28. TNF‑α‑mediated upregulation of SOD‑2 contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Liu B; Han X; Li Y; Wang W; Zhang Q; Lv P; Xing L; Shen H; Zhang X
Oncol Rep; 2019 Oct; 42(4):1497-1506. PubMed ID: 31364751
[TBL] [Abstract][Full Text] [Related]
29. Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase.
Mai S; Liu L; Jiang J; Ren P; Diao D; Wang H; Cai K
Cell Prolif; 2021 Feb; 54(2):e12960. PubMed ID: 33305406
[TBL] [Abstract][Full Text] [Related]
30. Tumor-associated macrophages promote human hepatoma Huh-7 cell migration and invasion through the Gli2/IGF-II/ERK1/2 axis by secreting TGF-β1.
Liu M; Zhong YB; Shao J; Zhang C; Shi C
Cancer Biol Ther; 2020 Nov; 21(11):1041-1050. PubMed ID: 33081566
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
32. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas.
Fang J; Ma Y; Li Y; Li J; Zhang X; Han X; Ma S; Guan F
Mol Carcinog; 2022 Nov; 61(11):1043-1055. PubMed ID: 36102200
[TBL] [Abstract][Full Text] [Related]
33. Infiltrated M2 tumour-associated macrophages in the stroma promote metastasis and poor survival in oesophageal squamous cell carcinoma.
Zhou J; Zheng S; Liu T; Liu Q; Chen Y; Ma R; Tan D; Lu X
Histol Histopathol; 2019 May; 34(5):563-572. PubMed ID: 30417922
[TBL] [Abstract][Full Text] [Related]
34. RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial‑mesenchymal transition through TGF‑β/Smad signaling.
Xiao Z; Tian Y; Jia Y; Shen Q; Jiang W; Chen G; Shang B; Shi M; Wang Z; Zhao X
Oncol Rep; 2020 Apr; 43(4):1289-1299. PubMed ID: 32323849
[TBL] [Abstract][Full Text] [Related]
35. Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma.
Liu A; Zhu J; Wu G; Cao L; Tan Z; Zhang S; Jiang L; Wu J; Li M; Song L; Li J
Mol Cancer; 2017 Jun; 16(1):106. PubMed ID: 28633632
[TBL] [Abstract][Full Text] [Related]
36. LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma.
Zhao F; Tian H; Wang Y; Zhang J; Liu F; Fu L
Cancer Immunol Immunother; 2023 Jun; 72(6):1835-1851. PubMed ID: 36688997
[TBL] [Abstract][Full Text] [Related]
37. TGF β1 promotes the polarization of M2-type macrophages and activates PI3K/mTOR signaling pathway by inhibiting ISG20 to sensitize ovarian cancer to cisplatin.
Wu J; Jiang L; Wang S; Peng L; Zhang R; Liu Z
Int Immunopharmacol; 2024 Jun; 134():112235. PubMed ID: 38761779
[TBL] [Abstract][Full Text] [Related]
38. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
39. Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN/PI3K/AKT signaling pathway.
Shou Y; Wang X; Chen C; Liang Y; Yang C; Xiao Q; Li H; Wang S; Shu J; Tian X; Chen K
Cancer Cell Int; 2022 Apr; 22(1):153. PubMed ID: 35436935
[TBL] [Abstract][Full Text] [Related]
40. TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway.
Liu Z; Kuang W; Zhou Q; Zhang Y
Int J Mol Med; 2018 Dec; 42(6):3395-3403. PubMed ID: 30320350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
